Matthew S. Holt Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Matthew S. Holt.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Matthew S. Holt. Matthew S. Holt is a Director in Bellerophon Therapeutics, Inc. ($BLPH) and a Director in Signify Health, Inc. ($SGFY).

Address: C/O NEW MOUNTAIN CAPITAL, L.L.C. 787 SEVENTH AVENUE, 49TH FLOOR NEW YORK 10019 NY

Companies in which Matthew S. Holt is an Insider

Bellerophon Therapeutics, Inc.

Trading Symbol: BLPH
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Matthew S. Holt: Director
Holdings: 18,232 shares
Current Value: $12,033
Latest Transaction: Jun 21 2016
$BLPH Market Capitalization: $9.84M
$BLPH Previous Close: $0.66

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Signify Health, Inc.

Trading Symbol: SGFY
Industry: SERVICES-HOME HEALTH CARE SERVICES [8082]
Position of Matthew S. Holt: Director
Holdings: 7,916 shares
Latest Transaction: Feb 17 2021

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of Matthew S. Holt

Sentiment: All, BLPH, SGFY

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Feb 17 2021SGFYSignify Health, In ...Holt Matthew S.DirectorGrantA0.007,91607,9160 to 7.9 K
Jun 21 2016BLPHBellerophon Therap ...Holt Matthew S.DirectorOption ExerciseA1.9410,00019,40010,000
Apr 29 2016BLPHBellerophon Therap ...Holt Matthew S.DirectorGrantA0.0018,232018,2320 to 18.2 K
Feb 23 2015BLPHBellerophon Therap ...Holt Matthew S.DirectorBuyP12.001,070,16612,841,9924,859,8853.8 M to 4.9 M (+28.24 %)
Feb 23 2015BLPHBellerophon Therap ...Holt Matthew S.DirectorGrantA0.00460,14403,789,7193.3 M to 3.8 M (+13.82 %)
Feb 23 2015BLPHBellerophon Therap ...Holt Matthew S.DirectorSellD0.00460,14403,329,5753.8 M to 3.3 M (-12.14 %)

View all Matthew S. Holt insider transactions.